Home | Site Map | Contact Us| Reference
 |
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Prostate Enlargement: Benign Prostatic Hyperplasia
Hope Through Research
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) was established by Congress in 1950 as one of the National Institutes of Health (NIH), whose mission is to improve human health through biomedical research. NIH is the research branch of the U.S. Department of Health and Human Services.
NIDDK conducts and supports a variety of research in diseases of the kidney and urinary tract. Much of the research targets disorders of the lower urinary tract, including BPH, urinary tract infection, interstitial cystitis, urinary obstruction, prostatitis, and urinary stones. The knowledge gained from these studies is advancing scientific understanding of why BPH develops and may lead to improved methods of diagnosing and treating prostate enlargement. One such study was the MTOPS Trial, which recently ended. The results are summarized above under Drug Treatment.
The Minimally Invasive Surgical Therapies (MIST) treatment group is looking at TUMT, TUNA, and other transurethral treatments for BPH that do not require a hospital stay.
Additional Reading
American Urological Association. Guideline on the management of benign prostatic hyperplasia: Chapter 1: Diagnosis and treatment recommendations. The Journal of Urology. 2003;170(2 Pt 1):530-537.
National Cancer Institute. Questions and answers about the prostate-specific antigen (PSA) test. http://cis.nci.nih.gov/fact/5_29.htm (accessed January 7, 2004).
What are the symptoms of Prostate Enlargement?
How is Prostate Enlargement diagnosed?
How is Prostate Enlargement treated?
